Journal ArticleArthritis Care Res (Hoboken) · January 2025
OBJECTIVE: Differential disease control may contribute to racial disparities in outcomes of childhood-onset systemic lupus erythematosus (cSLE). We evaluated associations of race and individual- or neighborhood-level social determinants of health (SDoH) wi ...
Full textLink to itemCite
Journal ArticleArthritis Care Res (Hoboken) · August 2024
OBJECTIVE: The objective of this study was to compare the effectiveness of a second tumor necrosis factor inhibitor (TNFi) versus a non-TNFi biologic following discontinuation of a TNFi for patients with polyarticular-course juvenile idiopathic arthritis ( ...
Full textLink to itemCite
Journal ArticleArthritis Care Res (Hoboken) · November 2023
OBJECTIVE: Health disparities in childhood-onset systemic lupus erythematosus (SLE) disproportionately impact marginalized populations. Socioeconomically patterned missing data can magnify existing health inequities by supporting inferences that may misrep ...
Full textLink to itemCite
Journal ArticleJ Rheumatol · August 2023
OBJECTIVE: Prompt escalation to tumor necrosis factor inhibitors (TNFis) is recommended for children with juvenile idiopathic arthritis (JIA) and ongoing disease activity despite treatment with conventional disease-modifying antirheumatic drugs (cDMARDs). ...
Full textLink to itemCite
Journal ArticleArthritis Care Res (Hoboken) · July 2023
OBJECTIVE: The goal was to characterize short-term kidney status and describe variation in early care utilization in a multicenter cohort of patients with childhood-onset systemic lupus erythematosus (cSLE) and nephritis. METHODS: We analyzed previously co ...
Full textLink to itemCite
Journal ArticleArthritis Care Res (Hoboken) · April 2023
OBJECTIVE: Children with well-controlled juvenile idiopathic arthritis (JIA) frequently experience flares after medication discontinuation, but the outcomes of these flares have not been well described. The objective of this study was to characterize the r ...
Full textLink to itemCite
Journal ArticleRheumatology (Oxford) · February 1, 2023
OBJECTIVE: To describe 2-year trajectories of the clinical Juvenile Arthritis Disease Activity Score, 10 joints (cJADAS10) and associated baseline characteristics in patients with JIA. METHODS: JIA patients in the Childhood Arthritis and Rheumatology Resea ...
Full textLink to itemCite
Journal ArticleJ Rheumatol · January 2023
OBJECTIVE: To evaluate patient-reported care utilization and outcomes among young adults with juvenile idiopathic arthritis (JIA), including factors associated with complete transfer to adult rheumatology. METHODS: We included young adults with JIA enrolle ...
Full textLink to itemCite
Journal ArticleClin Exp Rheumatol · January 2023
OBJECTIVES: This study assesses the association of race/ethnicity with the Patient-Reported Outcomes Measurement Information System (PROMISĀ®) in childhood-onset systemic lupus erythematosus (cSLE) patients from the Childhood Arthritis and Rheumatology Rese ...
Full textLink to itemCite
Journal ArticlePediatr Rheumatol Online J · December 8, 2022
BACKGROUND: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed consensus treatment plans (CTPs) to compare treatment initiation strategies for systemic juvenile idiopathic arthritis (sJIA). First-line options for sJIA treatment (F ...
Full textLink to itemCite
Journal ArticlePediatr Rheumatol Online J · November 25, 2022
BACKGROUND: Children with juvenile idiopathic arthritis (JIA) who achieve a drug free remission often experience a flare of their disease requiring either intraarticular steroids (IAS) or systemic treatment with disease modifying anti-rheumatic drugs (DMAR ...
Full textLink to itemCite
Journal ArticlePediatr Rheumatol Online J · July 19, 2022
BACKGROUND: To report baseline characteristics, patient reported outcomes and treatment of children with Juvenile Dermatomyositis (JDM) in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. METHODS: Children newly diagnosed with J ...
Full textLink to itemCite
Journal ArticlePediatr Rheumatol Online J · March 7, 2022
BACKGROUND: Social determinants of health (SDH) greatly influence outcomes during the first year of treatment in rheumatoid arthritis, a disease similar to polyarticular juvenile idiopathic arthritis (pJIA). We investigated the correlation of community pov ...
Full textLink to itemCite
ConferenceArthritis Care Res (Hoboken) · December 2021
OBJECTIVE: Down syndrome-associated arthritis (DA) is underrecognized, and current therapies used for juvenile idiopathic arthritis (JIA) appear to be poorly tolerated and less effective in patients with DA. The objective of this study was to characterize ...
Full textLink to itemCite
Journal ArticleJ Rheumatol · December 2021
OBJECTIVE: Autoimmune disorders result from the interplay of genetic and environmental factors. Many autoimmune disorders are associated with specific seasons of birth, implicating a role for environmental determinants in their etiopathology. We investigat ...
Full textLink to itemCite
Journal ArticleArthritis Rheumatol · October 2021
OBJECTIVE: To investigate the effects of early introduction of biologic disease-modifying antirheumatic drugs (bDMARDs) on the disease course in untreated polyarticular juvenile idiopathic arthritis (JIA). METHODS: We analyzed data on patients with polyart ...
Full textLink to itemCite
Journal ArticlePediatr Rheumatol Online J · August 21, 2021
BACKGROUND: We aimed to characterize etanercept (ETN) use in juvenile idiopathic arthritis (JIA) patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. METHODS: The CARRA Registry is a convenience cohort of patien ...
Full textLink to itemCite
Journal ArticlePediatr Rheumatol Online J · August 14, 2021
BACKGROUND: The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease morbidity; however, a potential barrie ...
Full textLink to itemCite
Journal ArticleRheumatology (Oxford) · August 2, 2021
OBJECTIVE: To evaluate the safety and efficacy of abatacept treatment for refractory juvenile localized scleroderma (jLS) in a retrospective study. METHODS: A multicentre cohort study was performed to evaluate jLS subjects treated with abatacept with follo ...
Full textLink to itemCite
Journal ArticleJ Rheumatol · August 2021
OBJECTIVE: Biologic medications have significantly improved disease control and outcomes of patients with juvenile idiopathic arthritis (JIA). Current treatment recommendations suggest escalating therapy, including changing biologics if needed, when inacti ...
Full textLink to itemCite
Journal ArticleArthritis Care Res (Hoboken) · July 2021
OBJECTIVE: To describe characteristics of children with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (PsA) who were enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. METHODS: All children with E ...
Full textLink to itemCite
Journal ArticlePediatr Clin North Am · February 2021
Children with rheumatic disease have rare pulmonary manifestations that may cause significant morbidity and mortality. These children are often clinically asymptomatic until disease has significantly progressed, so they should be screened for pulmonary inv ...
Full textLink to itemCite
Chapter · December 2, 2020
Pulmonary Manifestations of Rheumatic Diseases in Children Mary M. Buckley, MD , C. Egla Rabinovich, MD, MPH * KEYWORDS SLE JDMS JIA jSSc Sarcoid PFTs HRCT KEY POINTS Children with rheumatic disease have rare pulmonary manifestationsĀ ... ...
Full textCite
Journal ArticleCurr Allergy Asthma Rep · April 4, 2020
PURPOSE OF REVIEW: Idiopathic pulmonary hemosiderosis (IPH) is one of the rarest and least understood causes of pulmonary hemorrhage in children. Illustrated by a complex case presentation, we discuss the clinical manifestations, diagnosis, pathology, prop ...
Full textLink to itemCite
Journal ArticleJournal of Applied Remote Sensing · July 1, 2019
Hyperspectral infrared sounding in a CubeSat will provide a new dimension to the current suite of IR sounders by allowing measurements at multiple times of day and enabling formation flying of IR sounders for new data products such as atmospheric motion ve ...
Full textCite
ConferenceProceedings of SPIE - The International Society for Optical Engineering · January 1, 2018
Hyperspectral infrared sounding in a CubeSat will provide a new dimension to the current suite of IR sounders by allowing measurements at multiple times of day and enabling formation flying of IR sounders for new data products such as Atmospheric Motion Ve ...
Full textCite
ConferenceProceedings of SPIE - The International Society for Optical Engineering · January 1, 2017
The CubeSat Infrared Atmospheric Sounder (CIRAS) is a NASA Earth Science Technology Office (ESTO) sponsored mission to demonstrate key technologies used in very high spectral resolution infrared remote sensing of Earth's atmosphere from space. CIRAS was aw ...
Full textCite